InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
T+90 hit rate
0%
T+90 mean return
-22.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Sauer Paul, SVP, Développement des Processus. Insider active across 1 company, notably Vaxcyte, Inc.. Aggregated, 15 disclosures have been published. Split: 0 buy · 13 sells. Total volume traded: €1.2m. Activity tracked since 22 September 2021. The latest transaction was disclosed on 2 September 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
865 shares@ US$26.381.9% of flowCommon StockSEC:0001209191-22-049023:0
3,000 shares@ US$25.92836.4% of flowCommon StockSEC:0001209191-22-047354:0
3,000 shares@ US$25.006.0% of flowCommon StockSEC:0001209191-22-043547:0
3,000 shares@ US$25.006.0% of flowCommon StockSEC:0001209191-22-043024:0
3,000 shares@ US$26.22350.0012% mcap7.6% of flowCommon StockSEC:0001209191-22-031865:0
3,000 shares@ US$25.000.0011% mcap7.1% of flowCommon StockSEC:0001209191-22-025654:0
3,000 shares@ US$25.000.0011% mcap7.0% of flowCommon StockSEC:0001209191-22-020962:0
6,000 shares@ US$25.000.0022% mcap14.0% of flowCommon StockSEC:0001209191-22-018522:0
10,000 shares0Common StockSEC:0001209191-22-016522:0
6,000 shares@ US$25.0010.9% of flowCommon StockSEC:0001209191-21-071604
6,000 shares@ US$25.000.0022% mcap13.7% of flowCommon StockSEC:0001209191-21-071604:0
3,000 shares@ US$25.000.0011% mcap6.7% of flowCommon StockSEC:0001209191-21-062762:0
3,000 shares@ US$25.005.3% of flowCommon StockSEC:0001209191-21-062762
5,307 shares@ US$25.19770.0019% mcap11.8% of flowCommon StockSEC:0001209191-21-057651:0
5,307 shares@ US$25.19779.4% of flowCommon StockSEC:0001209191-21-057651
15 of 15 declarations
About Sauer Paul
Paul Sauer is the SVP Process Development and Manufacturing at Vaxcyte, Inc. He oversees process development and manufacturing initiatives, ensuring efficiency and quality of products. His role is essential in supporting Vaxcyte's growth.
